These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Shingles (herpes zoster) vaccine (zostavax(®)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years. Keating GM Drugs; 2013 Jul; 73(11):1227-44. PubMed ID: 23839657 [TBL] [Abstract][Full Text] [Related]
8. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia. Betts RF J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866 [TBL] [Abstract][Full Text] [Related]
10. Vaccination: a new option to reduce the burden of herpes zoster. Mick G Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716 [TBL] [Abstract][Full Text] [Related]
11. Why Postoperative Pain Remains a Problem. Lundborg C J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):300-2. PubMed ID: 26305515 [TBL] [Abstract][Full Text] [Related]
12. [Herpes zoster in old adults]. Lang PO; Belmin J; Michel JP Presse Med; 2009 Apr; 38(4):571-83. PubMed ID: 19028069 [TBL] [Abstract][Full Text] [Related]
13. A 70-year-old woman with shingles: review of herpes zoster. Whitley RJ JAMA; 2009 Jul; 302(1):73-80. PubMed ID: 19491172 [TBL] [Abstract][Full Text] [Related]
14. [Pain in herpes zoster: Prevention and treatment]. Calvo-Mosquera G; González-Cal A; Calvo-Rodríguez D; Primucci CY; Plamenov-Dipchikov P Semergen; 2017; 43(4):318-327. PubMed ID: 27053513 [TBL] [Abstract][Full Text] [Related]
15. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. Drolet M; Brisson M; Schmader KE; Levin MJ; Johnson R; Oxman MN; Patrick D; Blanchette C; Mansi JA CMAJ; 2010 Nov; 182(16):1731-6. PubMed ID: 20921251 [TBL] [Abstract][Full Text] [Related]
16. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. Holcomb K; Weinberg JM J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Amirthalingam G; Andrews N; Keel P; Mullett D; Correa A; de Lusignan S; Ramsay M Lancet Public Health; 2018 Feb; 3(2):e82-e90. PubMed ID: 29276017 [TBL] [Abstract][Full Text] [Related]
19. Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. Saguil A; Kane S; Mercado M; Lauters R Am Fam Physician; 2017 Nov; 96(10):656-663. PubMed ID: 29431387 [TBL] [Abstract][Full Text] [Related]
20. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status. Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]